BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8603860)

  • 1. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa.
    Milam AH; Li ZY; Cideciyan AV; Jacobson SG
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):753-65. PubMed ID: 8603860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry.
    Li ZY; Jacobson SG; Milam AH
    Exp Eye Res; 1994 Apr; 58(4):397-408. PubMed ID: 7925677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.
    Li ZY; Wong F; Chang JH; Possin DE; Hao Y; Petters RM; Milam AH
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):808-19. PubMed ID: 9538889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
    John SK; Smith JE; Aguirre GD; Milam AH
    Mol Vis; 2000 Nov; 6():204-15. PubMed ID: 11063754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa.
    Jacobson SG; Kemp CM; Cideciyan AV; Macke JP; Sung CH; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2521-34. PubMed ID: 8163341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant retinitis pigmentosa in a large family: a clinical and molecular genetic study.
    Rosas DJ; Roman AJ; Weissbrod P; Macke JP; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3134-44. PubMed ID: 8045708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
    Rosenfeld PJ; Hahn LB; Sandberg MA; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2186-92. PubMed ID: 7558711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic study of an unusual form of retinitis pigmentosa.
    Szamier RB; Berson EL
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):559-70. PubMed ID: 7076403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life history of cones in the rhodopsin-mutant P23H-3 rat: evidence of long-term survival.
    Chrysostomou V; Stone J; Valter K
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2407-16. PubMed ID: 19117918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked retinitis pigmentosa: functional phenotype of an RP2 genotype.
    Jacobson SG; Roman AJ; Cideciyan AV; Robey MG; Iwata T; Inana G
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3481-92. PubMed ID: 1464493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis.
    Milam AH; Barakat MR; Gupta N; Rose L; Aleman TS; Pianta MJ; Cideciyan AV; Sheffield VC; Stone EM; Jacobson SG
    Ophthalmology; 2003 Mar; 110(3):549-58. PubMed ID: 12623820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology.
    Machida S; Kondo M; Jamison JA; Khan NW; Kononen LT; Sugawara T; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3200-9. PubMed ID: 10967084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa.
    Birch DG; Anderson JL
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2288-99. PubMed ID: 2242994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed histopathologic characterization of the retinopathy, globe enlarged (rge) chick phenotype.
    Montiani-Ferreira F; Fischer A; Cernuda-Cernuda R; Kiupel M; DeGrip WJ; Sherry D; Cho SS; Shaw GC; Evans MG; Hocking PM; Petersen-Jones SM
    Mol Vis; 2005 Jan; 11():11-27. PubMed ID: 15660021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal histopathology of an XLRP carrier with a mutation in the RPGR exon ORF15.
    Aguirre GD; Yashar BM; John SK; Smith JE; Breuer DK; Hiriyanna S; Swaroop A; Milam AH
    Exp Eye Res; 2002 Oct; 75(4):431-43. PubMed ID: 12387791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.